MEDVi Cancellation Policy: Refunds, Deadlines & Renewal Terms

Last reviewed: September 24, 2026 Last updated: September 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

The short answer

MEDVi monthly plans carry no contract and can be canceled anytime, according to checkout-verified terms captured September 4, 2026. The service also offers 3-, 6-, and 12-month prepaid bundles with 0% financing, and those bundles are non-refundable for unused months. MEDVi's monthly billing follows an introductory-then-refill structure: semaglutide starts at a first-month introductory rate of $179, then refills at $299 per month; tirzepatide starts at $279, then refills at $399 per month. No written refund policy for monthly subscriptions appears in available sources beyond "cancel anytime." Over twelve months on month-to-month billing, MEDVi's semaglutide costs $3,468 and tirzepatide costs $4,668—$1,200 more per year than PlexusDx's flat month-to-month rates of $189 and $289, respectively.

At a glance: MEDVi cancellation, refund, and renewal terms

MEDVi pricing structure: introductory month vs. ongoing refills

MEDVi uses a two-tier pricing model. Semaglutide injection costs a first-month introductory rate of $179, then refills at $299 per month (checkout-verified September 4, 2026). Tirzepatide starts at a first-month introductory rate of $279, then refills at $399 per month. Semaglutide tablets add a $70 surcharge over injection, bringing the first-month rate to $249 and the ongoing refill to $369 per month. These rates apply regardless of dose; the checkout terms state that dose increases do not raise the monthly price. No membership fee applies to the compounded pathway; MEDVi does charge a separate $99/month membership for its branded Wegovy/Zepbound pathway, with medication cost additional.

Cancellation mechanics: monthly vs. prepaid commitment

On the monthly billing path, MEDVi's checkout terms declare "no contract; cancel anytime" (verified September 4, 2026). The service processes billing as a monthly refill form. How cancellation is executed—whether through account dashboard, email, or phone—is not documented in available sources; readers should confirm the cancellation process with MEDVi support before enrolling. No explicit refund policy text appears for monthly subscriptions beyond the "cancel anytime" statement, so whether a partial refund is available if you cancel mid-cycle, or whether the current month runs to term, remains unclear.

For prepaid bundles (3-, 6-, and 12-month commitments with 0% financing, captured July 20, 2026), MEDVi's terms are stricter: bundles are non-refundable for unused months. This means if you prepay for six months and discontinue after two, you forfeit the remaining four months' value. The exact per-month rate for these bundles is not published by MEDVi in available sources, so a direct cost-per-month comparison to monthly billing cannot be completed.

Normalized 12-month cost: MEDVi month-to-month vs. PlexusDx

Comparing the two providers on identical month-to-month terms over one year:

12-month totals are our calculation, using MEDVi's checkout-verified rates (September 4, 2026) and PlexusDx's published month-to-month prices. MEDVi's prepaid bundle rates are not publicly available, so no like-for-like prepaid comparison is possible.

On both compounds, MEDVi's introductory discount is offset by the higher refill rate, producing a $1,200 cost difference over one year on month-to-month billing. PlexusDx holds the same price at every dose and every month; MEDVi's price jumps after the first fill but then remains flat regardless of dose escalation.

Renewal terms and dose escalation

MEDVi bills monthly via a refill form. Once you complete the first introductory month, each subsequent month renews at the standard refill rate ($299 semaglutide, $399 tirzepatide). The checkout terms confirm that dose increases do not trigger a price increase—your monthly cost remains the same whether you stay at a starting dose or escalate to a maintenance level. This policy matches PlexusDx's flat-rate-at-every-dose model, though PlexusDx applies that principle from month one rather than after an introductory tier.

For prepaid bundles, renewal mechanics differ: you commit to 3, 6, or 12 months upfront with 0% financing. The bundle is non-refundable for unused months, so if your clinical course changes—side effects, inadequate response, contraindication—you cannot recover the prepaid value. Monthly plans offer more exit flexibility but cost significantly more over time.

What the refund-policy gap means for buyers

Available sources confirm MEDVi monthly plans carry "no contract; cancel anytime" language, but no explicit refund policy text appears for monthly subscriptions. Key unanswered questions include:

• If you cancel mid-cycle, does the current month run to term, or is a prorated refund issued?
• What is the cancellation notice period—same-day, 24 hours, end of billing cycle?
• Is cancellation self-service (account dashboard) or does it require contacting support?

Before enrolling, confirm these mechanics directly with MEDVi support or review the full terms of service at checkout. For prepaid bundles, the policy is unambiguous: non-refundable for unused months.

Choose MEDVi if…

• You want the lowest possible first-month cost and are confident you will continue long enough to absorb the higher refill rate.
• You prefer 0% financing on a prepaid bundle and are certain your clinical course will not change within the commitment window.
• You value same-price-at-every-dose protection once you pass the introductory tier.

Choose PlexusDx if…

• You want predictable, flat monthly pricing from month one—no introductory tier, no refill jump.
• You prefer genuine month-to-month flexibility without prepayment risk; PlexusDx's cancel-anytime monthly option costs $1,200 less over one year than MEDVi's for both semaglutide and tirzepatide.
• You want transparent refund and cancellation terms without gaps in the published policy.
• You are exploring microdose GLP-1 maintenance at $129/month, a protocol MEDVi does not offer.

PlexusDx also offers multi-month commitments (3- and 6-month) at lower per-month rates than month-to-month, with refund terms published in the terms of service. The 6-month semaglutide commitment runs $149/month ($894 total), and the 6-month tirzepatide commitment runs $249/month ($1,494 total)—both figures far below MEDVi's 12-month month-to-month totals, and with defined cancellation and refund policies. PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026).

Methodology and freshness

MEDVi's monthly rates, cancellation terms, and dose-increase policy were verified at checkout on September 4, 2026. Prepaid bundle terms (non-refundable for unused months, 0% financing) were captured from MEDVi's public marketing on July 20, 2026; exact per-month bundle pricing was not published and is therefore not included in this analysis. PlexusDx's pricing and terms reflect published rates as of September 24, 2026. The 12-month cost totals are our calculation, applying verified monthly rates across one year. All prices are for compounded semaglutide and tirzepatide; neither MEDVi nor PlexusDx figures include branded medication pathways. We recommend confirming cancellation process, refund mechanics, and prepaid bundle pricing directly with MEDVi before enrollment.

Frequently Asked Questions

Can I cancel my MEDVi subscription at any time?

Yes, if you are on the monthly billing plan. MEDVi's checkout terms state "no contract; cancel anytime" (verified September 4, 2026). Prepaid 3-, 6-, and 12-month bundles are non-refundable for unused months, so canceling a prepaid commitment forfeits the remaining value.

Does MEDVi refund unused medication or partial months?

No explicit refund policy for monthly subscriptions appears in available sources beyond "cancel anytime." Whether you receive a prorated refund if you cancel mid-cycle, or whether the current month runs to term, is not documented. Confirm refund mechanics with MEDVi support before enrolling.

What happens if I need to stop MEDVi due to side effects or medical reasons?

On a monthly plan, you can cancel anytime under the no-contract terms, though refund details are not published. On a prepaid bundle, the commitment is non-refundable for unused months even if a clinical issue requires discontinuation. Consult your prescribing provider and MEDVi support to understand your options.

How much does MEDVi cost over one year compared to PlexusDx?

On month-to-month billing, MEDVi's semaglutide totals $3,468 over twelve months (first month $179, then eleven months at $299); PlexusDx's flat $189/month totals $2,268—a $1,200 difference (our calculation). For tirzepatide, MEDVi totals $4,668 versus PlexusDx's $3,468, also a $1,200 difference.

Does MEDVi charge more when my dose increases?

No. MEDVi's checkout terms confirm that dose increases do not raise the monthly price (verified September 4, 2026). Once you move past the introductory first month, your refill rate remains $299/month for semaglutide or $399/month for tirzepatide regardless of dose escalation—the same policy PlexusDx applies from month one.

Sources

• PlexusDx weight-loss provider comparison page (MEDVi prepaid bundle terms, non-refundable policy), accessed July 20, 2026
• MEDVi checkout terms and pricing (monthly rates, cancellation language, dose-increase policy), verified September 4, 2026
• PlexusDx published pricing and terms of service, accessed September 24, 2026
• Trustpilot.com/review/plexusdx.com (PlexusDx review record), accessed September 9, 2026

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.